Quality assessment of included studies using QI-MCS (met=1, not met=0)
| Organi- sational motivation | Inter- vention rationale | Inter- vention description | Organi- sational characteristics | Imple- mentation | Study design | Com- parator | Data source | Timing | Adherence/ fidelity | Health outcomes | Organi- sational readiness | Penetration/ reach | Sustain- ability | Spread | Limitations | Total (max possible=16) | |
| McLeod (2003)26 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 9 |
| Kuper (2011)27 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 13 |
| McNaney (2011)23 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 8 |
| Potgieter (2012)19 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 10 |
| Huddart (2015)20 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 13 |
| Standards for QUality Improvement Reporting Excellence 2.0 guidelines41 published (2016) | |||||||||||||||||
| Feinberg (2018)24 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 12 |
| Aggarwal (2019)21 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 11 |
| Peden (2019)22 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 12 |
| Tadd (2019)28 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 11 |
| Bamber (2019)25 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 12 |
QI-MCS, Quality Improvement Minimum Criteria Set.